Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27360648 | 1.00 | HCAR2 (0.53) | HCAR2KEAP1NFE2L2ATMALDH1A1 | |
| SCHEMBL23544811 | 0.92 | NFE2L2 (0.68) | HCAR2KEAP1NFE2L2ALDH1A1KDM4E | |
| SCHEMBL23557517 | 0.92 | NFE2L2 (0.68) | HCAR2KEAP1NFE2L2ALDH1A1KDM4E | |
| SCHEMBL28997788 | 0.87 | HCAR2 (0.42) | HCAR2KEAP1NFE2L2ALDH1A1MAPT | |
| SCHEMBL11898397 | 0.86 | — | — | |
| SCHEMBL11898399 | 0.86 | — | — | |
| SCHEMBL25177277 | 0.80 | — | — | |
| SCHEMBL27855095 | 0.79 | — | — | |
| SCHEMBL7745504 | 0.77 | — | — | |
| SCHEMBL25056786 | 0.77 | AKT1 (0.42) | HCAR2KEAP1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2964827-B1 | VENTILATION INSERT | FREUDENBERG CARL KG (DE) | 2019-11-06 | — | — | EP | claimed |
| EP-1161565-B1 | USE OF SUPERABSORBENT POLYMERS FOR TREATING RAW SKINS, CORRESPONDING COMPOSITIONS AND METHODS AND RESULTING TREATED SKINS | SNF SA (FR) | 2009-10-28 | — | — | EP | claimed |
| US-20260103885-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | GOLD BOND BUILDING PRODUCTS LLC (US) | 2026-04-16 | — | — | US | disclosed |
| US-20250288972-A1 | Nanoporous Superabsorbent Particles with Low Non-Solvent Levels | KIMBERLY-CLARK WORLDWIDE, INC. | 2025-09-18 | — | — | US | disclosed |
| US-12337297-B2 | Nanoporous superabsorbent particles with low non-solvent levels | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2025-06-24 | — | — | US | disclosed |
| WO-2025129030-A1 | PROCESS FOR PRODUCING ABSORBENT SUBSTRATES | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20250052057-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | BANK OF AMERICA, N.A., AS COLLATERAL AGENT | 2025-02-13 | — | — | US | disclosed |
| US-12194435-B2 | Nanoporous superabsorbent particles | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| US-20250001395-A1 | Microporous Superabsorbent Material | KIMBERLY-CLARK WORLDWIDE, INC. | 2025-01-02 | — | — | US | disclosed |
| US-12152385-B2 | Cementitious panels with swellable materials and methods of providing a moisture or water barrier in cementitious panels using swellable materials | GOLD BOND BUILDING PRODUCTS, LLC (US) | 2024-11-26 | — | — | US | disclosed |
| US-20240375081-A1 | Microporous Superabsorbent Material with Enhanced Surface Area | KIMBERLY-CLARK WORLDWIDE, INC. | 2024-11-14 | — | — | US | disclosed |
| EP-0783294-A1 | TOPICAL AQUEOUS SKIN CARE COMPOSITION WITH HYDROGEL THICKENER AND WATER INSOLUBLE SILICONE CONDITIONING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 1997-07-16 | — | — | EP | disclosed |
| EP-0779804-A1 | CLEAR, THICKENED TOPICAL SKIN CARE COMPOSITION WITH WATER-INSOLUBLE PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-25 | — | — | EP | disclosed |
| WO-1997007779-A1 | SKIN CONDITIONING COMPOSITION CONTAINING SILICONE GUM, MIXTURE OF POLYOXYETHYLENES AND GLYCEROL COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1997-03-06 | — | — | WO | disclosed |
| US-5605681-A | POLY-HYDROXY SOLVENT FOR SOAP GELLING AGENT | THE PROCTOR & GAMBLE COMPANY (US) | 1997-02-25 | — | — | US | disclosed |
| US-5585092-A | USING GLYCEROL AND AN ETHYLENE OXIDE ADDUCT AS SOLVENTS TO REPLACE IRRITATING PROPYLENE GLYCOL; ALSO INCLUDING A SOAP GELLING AGENT OF A FATTY ACID SALT, WATER AND FRAGRANCE; ANTIPERSPIRANTS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-17 | — | — | US | disclosed |
| WO-1996032091-A2 | GEL DEODORANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-10-17 | — | — | WO | disclosed |
| WO-1996014054-A1 | TOPICAL AQUEOUS SKIN CARE COMPOSITION WITH HYDROGEL THICKENER AND WATER INSOLUBLE SILICONE CONDITIONING AGENT | THE PROCTER & GAMBLE COMPANY (US) | 1996-05-17 | — | — | WO | disclosed |
| WO-1996007395-A1 | CLEAR, THICKENED TOPICAL SKIN CARE COMPOSITION WITH WATER-INSOLUBLE PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-14 | — | — | WO | disclosed |
| US-4076663-A | POLYMERIZING WITH UNSATURATED MONOMER, CROSSLINKING, HYDROLYZING | SANYO CHEMICAL INDUSTRIES, LTD. (JA) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103885-A1 | Cementitious Panels with Swellable Materials and Methods of Providing a Moisture or Water Barrier in Cementitious Panels Using Swellable Materials | DSG1, AQP4, WAPL | HCAR2 4848/4885KEAP1 4377/4885NFE2L2 4570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.